-+ 0.00%
-+ 0.00%
-+ 0.00%

Clover Health Stock and Two Penny Stocks With Stronger Balance Sheets

Simply Wall St·08/23/2026 11:19:55
语音播报

Government bond yields are trending higher in many regions, and that puts the spotlight on companies with cleaner balance sheets and more disciplined finances. Higher borrowing costs can pressure weaker businesses, so investors are paying closer attention to financial health. The Financially Fit Penny Stocks screener focuses on that theme. This article highlights three screened stocks that combine penny stock pricing with relatively stronger fundamentals.

The three stocks highlighted next are only a small sample, with the full Financially Fit Penny Stocks screen surfacing another 312 companies that also have detailed narratives but are not covered here. If you want to go beyond this short list and identify candidates that best match your own risk and balance sheet preferences, head straight to the Financially Fit Penny Stocks screener.

TOYO (TOYO)

TOYO Co., Ltd. is a Tokyo based solar manufacturer that produces wafers, cells and photovoltaic modules for projects across Asia and the United States, placing its PV modules and solar cells within the Financially Fit Penny Stocks renewable energy theme. The company currently reports all of its roughly $549 million in revenue under a Machinery & Industrial Equipment segment, with operations serving customers primarily in the US and other regions. TOYO has a market cap of about $206 million, which keeps it in penny stock territory while still giving it meaningful scale in the solar supply chain.

Investors looking at TOYO are getting direct exposure to solar manufacturing with a focus on PV modules and cells, along with a company that reports growing earnings and improving net margins, now at 14.1%. The situation includes some tensions, including heavy reliance on external borrowing and an inexperienced leadership team running a capital hungry expansion across Ethiopia and the US. Yet with reported strong return on equity, a low P/E, and US facility plans backed by new supply agreements, TOYO presents a mix of financial discipline and expansion activity that some investors may evaluate more closely beyond the headlines and recent share price swings.

TOYO’s rising net margins and low P/E suggest that investors may be missing something in this solar expansion story. Get the full picture, including what that capital hungry growth push could mean next, in the 4 key rewards and 1 important major warning sign

NasdaqCM:TOYO P/E Ratio as at Aug 2026
NasdaqCM:TOYO P/E Ratio as at Aug 2026

Build your own financially fit penny stock shortlist

TOYO and the other two stocks in this article all surfaced from a single screen, but the real edge comes from shaping filters around your own style. Use our flexible Screener to combine valuation, future growth, balance sheet strength and risk checks, or jump straight into our curated Investing Ideas for ready made starting points.

Clover Health Investments (CLOV)

Clover Health Investments runs a Medicare Advantage insurance business that sells PPO and HMO plans to Medicare eligible beneficiaries, which directly links it to the Financially Fit Penny Stocks theme through health plan economics and medical cost control. The company generates about US$2.5b in revenue from its Insurance segment in the United States and also offers Clover Assistant, a software platform that helps physicians manage chronic disease and support those plans. With a market cap of about US$2.2b, Clover Health Investments is a penny stock by share price rather than size, which gives it scale more in line with established insurers than many early stage peers.

Investors watching financial health in smaller cap stocks may find Clover Health Investments interesting because its Medicare Advantage engine is paired with the Clover Assistant software platform, which aims to keep medical costs in check and support margin improvement. Analysts currently expect strong earnings growth and see the stock trading well below their estimates of fair value, which puts a spotlight on whether improving membership mix, 4 star and 4.5 star ratings and tighter cost control can turn shrinking losses into durable profitability. The catch is that Clover remains loss making, relies heavily on external funding and has seen recent insider selling, so the real question is whether the improving operating story is strong enough to offset those risks over time.

Losses are shrinking while Clover Health Investments pushes its Medicare Advantage engine and software story harder, yet the real turning point is easy to miss. Get the context, numbers and the key pressure points in the analysis report for Clover Health Investments

NasdaqGS:CLOV Earnings & Revenue Growth as at Aug 2026
NasdaqGS:CLOV Earnings & Revenue Growth as at Aug 2026

Hyliion Holdings (HYLN)

Hyliion Holdings is a Texas based developer of the KARNO Power Module, a fuel flexible generator aimed at cleaner distributed power for data centers, defense and industrial customers. This is the core link to the Financially Fit Penny Stocks theme. The company currently reports about $9 million in revenue from a single Auto Parts & Accessories segment in the United States and has a market cap of roughly $595 million, putting it in penny stock territory by share price rather than size.

Hyliion Holdings may be worth a closer look for investors who care about the shift to cleaner, on site power and who accept early stage risk. The company is still loss making and relies on external funding. It now has a $41.7 million U.S. Navy contract, has raised 2026 revenue guidance to about $15 million, and is reporting progress on tripling additive manufacturing throughput for KARNO systems. Those pieces, plus letters of intent for hundreds of KARNO cores and reported interest from AI data center operators, indicate a potential pipeline that could reshape the financial profile if commercialization and cost control stay on track.

Hyliion Holdings is shifting from concept to contracts, with the U.S. Navy deal and KARNO interest pointing to a story many investors may not have fully priced in yet. Get the next layer of context in the analysis report for Hyliion Holdings

NYSEAM:HYLN Earnings & Revenue Growth as at Aug 2026
NYSEAM:HYLN Earnings & Revenue Growth as at Aug 2026

Seeking Alternatives Before Others Catch On

Fresh ideas can move from quiet to flying quickly. Spot potential opportunities while they are still under the radar. Consider researching them early.

  • Track companies involved in crypto and blockchain by scanning the curated 20 cryptocurrency and blockchain stocks before they attract wider attention.
  • Focus on cash generative miners with staying power by reviewing the hand picked 32 elite gold producer stocks while valuations and sentiment may still offer attractive conditions.
  • Monitor the AI build out by scouting infrastructure suppliers through the targeted 55 AI infrastructure stocks and identify potential candidates before the theme becomes more broadly followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.